Who is sponsoring NCT06173791?

NCT06173791 is sponsored by The University of Texas Health Science Center at San Antonio.

What condition does NCT06173791 study?

NCT06173791 studies Bone Loss in Jaw.

What drugs are being tested in NCT06173791?

Interventions: DFDBA fibers, DFDBA particles, DBBM.

What is the status of NCT06173791?

NCT06173791 is currently COMPLETED.

Last reviewed 2026-02-20 · How we verify

Demineralized Bone Allograft Fibers Versus Particulate In Sinus Augmentation

NCT06173791 NA COMPLETED

The purpose of this clinical trial is to assess if the addition of DFDBA fibers to DBBM results in greater vital bone formation than the addition of DFDBA particles to DBBM. The study team will examine the effects of the addition of DFDBA fibers to DBBM on vital bone formation. Specifically, we will assess histologically the percent vital bone formation with each of the groups during implant placement, six months after the sinus augmentation procedure. We will also evaluate the radiographic volume achieved with both groups of materials.

Details

Lead sponsor	The University of Texas Health Science Center at San Antonio
Phase	NA
Status	COMPLETED
Enrolment	26
Start date	Mon Sep 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Feb 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Bone Loss in Jaw

Interventions

DFDBA fibers
DFDBA particles
DBBM

Countries

United States